Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

RecruitingOBSERVATIONAL
Enrollment

1,025

Participants

Timeline

Start Date

November 18, 2014

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
CancerDermatologic Conditions
Interventions
BEHAVIORAL

Quality of Life (QoL) Assessment

Per physician's discretion, the patient (or, if applicable, patient's family member/ spouse/ caregiver for FDLQI) will complete one or more of the following dermatology-specific QoL instruments: Skindex-16, Skindex-29 DLQI (Dermatology Life Quality Index), FDLQI (Family DLQI) - for patient's family member/spouse/caregiver ONLY, CDLQI (Children's DLQI;Cartoon version) - for patient's under the age of 18 ONLY-written, CDLQI (Children's DLQI; Cartoon version) - for patients under the age of 18 ONLY - cartoon version, FACT-G (Functional Assessment of Cancer Thearpy-General), FACT-Melanoma (Functional Assessment of Cancer Therapy-Melanoma), SCI (Skin Cancer Index) FACT-EGFRI-18 (Functional Assessment of Cancer Therapy-Epidermal Growth Factor Receptor Inhibitor-18), HFS-14 (Hand-Foot Syndrome) OMWQ (Oral Mucositis Weekly Questionnaire), ESTEEM, Hairdex , Skindex-29 modified for hair loss, Itchy QoL,CADS (Chemotherapy-induced alopecia distress scale)

Trial Locations (4)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester, Harrison

11788

RECRUITING

Memorial Sloan Kettering Suffolk- Hauppauge, Hauppauge

Unknown

RECRUITING

Memorial Sloan Kettering Cancer Center, Basking Ridge

All Listed Sponsors
collaborator

Comprehensive Cancer Centre The Netherlands

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER